Literature DB >> 31876111

Early development of decreased β-cell insulin secretion in children and adolescents with hemoglobin H disease and its relationship with levels of anemia.

Pairunyar Nakavachara1, Worarat Kajchamaporn1, Julaporn Pooliam2, Vip Viprakasit3.   

Abstract

BACKGROUND: Diabetes mellitus (DM) associated with iron overload has been reported among adults with transfusion-dependent thalassemia and those with non-transfusion-dependent thalassemia (NTDT), especially in β-thalassemia disease. However, little is known about glucose metabolism and how early its dysregulation can develop in α-thalassemia hemoglobin H (Hb H) disease, which is one of the most common types of NTDT worldwide. PROCEDURE: We prospectively calculated glucose metabolism index in 40 patients (aged 10-25 years) with Hb H disease. Glucose metabolism data were compared between patients with deletional versus nondeletional Hb H, and between patients with normal versus abnormal insulin secretion/sensitivity.
RESULTS: Despite normal glucose tolerance in all patients, 52.5% had abnormal insulinogenic index indicating decreased β-cell insulin secretion. Patients with functional hemoglobin < 8 g/dL had significantly higher percentages of abnormal insulinogenic index. There was no significant difference in abnormal insulinogenic index between deletional and nondeletional Hb H.
CONCLUSION: Decreased β-cell insulin secretion is highly prevalent among children and adolescents with Hb H disease, and it is associated with levels of functional anemia at baseline, but not with the type of Hb H disease. This result warrants heightened awareness among hematologists due to potentially increased risk of DM later in life.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  HOMA-IR; HOMA-β; Hb H disease; glucose metabolism; insulin; insulinogenic index

Mesh:

Substances:

Year:  2019        PMID: 31876111     DOI: 10.1002/pbc.28109

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  1 in total

1.  An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines.

Authors:  Supachai Ekwattanakit; Chattree Hantaweepant; Archrob Khuhapinant; Noppadol Siritanaratkul; Vip Viprakasit
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.